[New post] Can Mid-Cap Lantheus Continue its 2022 Outperformance?

Editorial Team posted: "Mid-cap Lantheus Holdings has been on a revenue growth spurt boosted by a new product called Pylarify, which helps detect prostate cancer in an imaging test. Find out more at https://ift.tt/fFWDEYb via Entrepreneur.com" Technology & Business News Can Mid-Cap Lantheus Continue its 2022 Outperformance? Editorial Team Oct 28 Mid-cap Lantheus Holdings has been on a revenue growth spurt boosted by a new product called Pylarify, which helps detect prostate cancer in an imaging test. Find out more at https://ift.tt/fFWDEYb via Entrepreneur.com Read more of this post Like Unsubscribe to no longer receive posts from Technology & Business News. Change your email settings at manage subscriptions. Trouble clicking? Copy and paste this URL into your browser: https://technologyandbusinessnews.wordpress.com/2022/10/28/can-mid-cap-lantheus-continue-its-2022-outperformance/ Powered by WordPress.com